| | | % |
| Gender, female ( = 2,654) | 1,659 | 62.5% |
| Insurance status, public ( = 2,587) | 2,494 | 96.4 |
| Nonsmoker ( = 2,638) | 2,052 | 77.8 |
| Patients with ≥1 self-reported chronic condition | 1,086 | 39.9 | Hypertension | 608 | 56 | Chronic pain/arthritis | 257 | 23.7 | Heart disease | 242 | 22.3 | Diabetes | 221 | 20.3 | Asthma/chronic bronchitis | 197 | 18.1 | Depression | 143 | 13.2 | Chronic kidney disease | 55 | 5.1 |
| Age, mean ± SD ( = 2,644) | 46.7 ± 16.8 |
| Years of formal education, mean ± SD ( = 2,557) | 12.8 ± 4.49 |
| Number of tablets used daily, mean ± SD ( = 2,318) | 2.0 ± 2.7 | Patients with ≥1 tablet daily ( = 1,467) | | ASA/aspirin | 314 | 21.4 | Oral contraceptive | 165 | 11.2 | Anticoagulants | 80 | 5.5 |
| Participating countries ( = 2,724) | | | Austria° | 110 | 4 | Finland# | 107 | 3.9 | France, 3 sites+# | 325 | 11.9 | Germany, 3 sites+°# | 385 | 14.1 | Israel+ | 123 | 4.5 | Italy, 2 sites#° | 161 | 5.9 | Macedonia° | 364 | 13.4 | Poland, 2 sites+ | 241 | 8.8 | Slovenia° | 119 | 4.4 | Spain+ | 86 | 3.2 | Sweden+ | 98 | 3.6 | Turkey, 5 sites°+ | 605 | 22.2 |
|
|